AMG510

Overview

AMG-510 is a potent KRAS G12C covalent inhibitor with potential antineoplastic activity. At the 2019 World Conference on Lung Cancer (WCLC), Amgen declared the efficacy of AMG 510 for treating non-small cell lung cancer (NSCLC) with KRAS G12 C-mutated solid tumors. Amgen also announced prospective directions for AMG510 through academic scholars and reports the few limitations on official drug release as evidence for potential investors to consider the value of AMG 510.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | K-Ras

Product Information

• Catalog No.: B2693-291051
• CAS No.: 2252403-56-6
• Molecular Formula: C30H30F2N6O3
• Molecular Weight: 560.59
• Purity: ≥98%
• Solubility: Soluble in DMSO.

Source

Original product source